Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer- A single-arm phase II trial (NeoImmunoboost, AGO-B-041)

DSpace Repository

Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer- A single-arm phase II trial (NeoImmunoboost, AGO-B-041)

Author: Fasching, Peter A.; Hein, Alexander; Kolberg, Hans-Christian; Haeberle, Lothar; Uhrig, Sabrina; Ruebner, Matthias; Belleville, Erik; Hack, Carolin C.; Fehm, Tanja N.; Janni, Wolfang; Hartmann, Arndt; Erber, Ramona; Theuser, Anna-Katharin; Brucker, Sara Y.; Hartkopf, Andreas D.; Untch, Michael
Tübinger Autor(en):
Brucker, Sara
Published in: European Journal of Cancer (2023), Bd. 184, S. 1-9
Verlagsangabe: Elsevier Sci Ltd
Language: English
Full text: http://dx.doi.org/10.1016/j.ejca.2023.01.001
ISSN: 0959-8049
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)